Dr. Kuefler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1329 N Beaver St
Ste 1
Flagstaff, AZ 86001Phone+1 928-773-2260Fax+1 928-773-2402- Is this information wrong?
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 1984 - 1986
- Oregon Health & Science UniversityResidency, Internal Medicine, 1976 - 1979
- Keck School of Medicine of the University of Southern CaliforniaClass of 1976
Certifications & Licensure
- OR State Medical License 1977 - 2025
- AZ State Medical License 2021 - 2024
- CO State Medical License 1980 - 2017
- MT State Medical License 1986 - 2008
- WY State Medical License 1987 - 1992
- NM State Medical License 1980 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACP) American College of Physicians, 2004
Publications & Presentations
PubMed
- 14 citationsResults of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.Nicholas J. Robert, Paul Conkling, Mark Allen O'Rourke, Paul R. Kuefler, Kristi J. McIntyre, Feng Zhan, Lina Asmar, Yanping Wang, Oluwatoyin O. Shonukan, Joyce O'Shaug...> ;Breast Cancer Research and Treatment. 2011 Feb 1
- 41 citationsGemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative studyDonald A. Richards, Paul R. Kuefler, Lalan S. Wilfong, Robert H. Gersh, Kristi A. Boehm, Feng Zhan, Lina Asmar, Scott P. Myrand, Rebecca R. Hozak, Luping Zhao, John F....> ;Investigational New Drugs. 2011 Feb 1
- 10 citationsResults of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.Thomas H. Cartwright, Paul R. Kuefler, Allen Lee Cohn, William J. Hyman, Maury Berger, Donald A. Richards, Svetislava J. Vukelja, John E. Nugent, Robert L. Ruxer, Kris...> ;Clinical Colorectal Cancer. 2008 Nov 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Flagstaff Medical CenterFlagstaff, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: